Table 1.
n = 557 | Median (IQR) or Number (%) |
---|---|
Age, years old | 60 (52-70) |
Gender; Male (%) | 474 (85.1%) |
BMI, kg/m2 | 24.4 (22.1-27.1) |
Diabetes mellitus (%) | 154 (27.6%) |
Hypertension (%) | 373 (67.0%) |
Dyslipidemia (%) | 388 (69.7%) |
Smoking (%) | 377 (67.7%) |
Laboratory findings | |
BNP, pg/mL | 26.5 (11.2-74.8) |
Albumin, g/dL | 4.0 (3.8-4.3) |
eGFR, ml/min/1.73m2 | 78.0 (67.0-90.0) |
Hb, g/dL | 14.2 (13.1-15.0) |
HbA1c, % | 5.8 (5.6-6.4) |
TG, mg/dL | 81 (51-139) |
LDL-C, mg/dL | 120 (94-145) |
HDL-C, mg/dL | 50 (42-61) |
CRP, mg/dL | 0.08 (0.04-0.28) |
Hemodynamic findings | |
Blood Pressure, mmHg | |
Systolic | 137 (122-154) |
Diastolic | 79 (69-88) |
Mean | 105 (93-114) |
LVEDP, mmHg | 15 (11-20) |
LVEDV, mL | 105.5 (87.5-125.1) |
LVEDVI, mL/m2 | 59.8 (50.2-69.7) |
LVESV, mL | 45.3 (35.1-57.1) |
LVESVI, mL/m2 | 25.2 (20.2-31.8) |
LVEF, % | 56.7 (49.8-63.0) |
Diagnosis | |
Myocardial infarction (%) | 277 (49.7%) |
Unstable angina (%) | 280 (50.3%) |
Rhythm | |
Sinus rhythm | 537 (96.4%) |
Atrial fibrillation | 12 (2.2%) |
Others | 8 (1.4%) |
Medications | |
ACE inhibitors (%) | 19 (3.4%) |
ARBs (%) | 159 (28.5%) |
ARNIs (%) | 2 (0.4%) |
Beta blockers (%) | 83 (14.9%) |
Calcium channel blockers (%) | 191 (34.3%) |
Diuretics (%) | 34 (6.1%) |
Abbreviations: ACE = angiotensin converting enzyme; ARB = angiotensin II type I-receptor blockers; ARNI = angiotensin receptor neprilysin inhibitor; BMI = body mass index; BNP = B-type natriuretic peptide; CRP = C-reactive protein; eGFR = estimated glomerular filtration rate; Hb = hemoglobin; HbA1c = hemoglobin A1c; HDL-C = high-density lipoprotein; IQR = interquartile range; LDL-C = low-density lipoprotein; LVEDP = left ventricular end-diastolic pressure; LVEDV = left ventricular end-diastolic volume; LVEDVI = left ventricular end-diastolic volume index; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; LVESVI = left ventricular end-systolic volume index; TG = triglycerides.